Daniel A Norris

4PUBLICATIONS
6CO-AUTHORS
Gene and molecular therapyNanotoxicology, health and safetyCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 16, 2023
Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.

Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn

|May 24, 2023
Development of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasma.

Yumi Yamamoto, Patricia Sanwald Ducray, Marcus Björnsson

|Apr 24, 2023
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.

Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn

|Oct 26, 2019
Bioanalysis considerations on the pharmacokinetic evaluation of antisense therapeutics.

Daniel A Norris, Noah Post, Rosie Z Yu

Pageof 1

Frequent Collaborators

2 joint publications

Catherine J Mummery

2 joint publications

Simon Ducharme

2 joint publications

Juha O Rinne

2 joint publications

Eric E Swayze